Table A8.

Five-Year Overall Survival of Non-Infants (older than age 1 year) by Era

Patient Group	Total No. of Patients	5-Year Survival ± SE (%)						% Reduction 2000-2005 v 1990-1994	P
		1990-1994		1995-1999		2000-2005
		%	No. of Patients	%	No. of Patients	%	No. of Patients
All patients	21,165	84.4 ± 0.4	7,150	88.5 ± 0.4	7,021	91.3 ± 0.4	6,994	44	< .001
Sex
Male	11,922	83.4 ± 0.6	4,035	86.9 ± 0.6	3,992	90.9 ± 0.6	3,895	45	< .001
Female	9,243	85.8 ± 0.6	3,115	90.6 ± 0.6	3,029	91.8 ± 0.7	3,099	42	< .001
Race
White	15,437	87.0 ± 0.5	5,196	89.7 ± 0.5	4,289	92.0 ± 0.5	5,412	38	< .001
Black	1,449	75.7 ± 2.0	509	81.3 ± 1.8	517	88.4 ± 2.1	423	52	< .001
Other	4,279	77.8 ± 1.2	1,445	87.3 ± 0.9	1,675	89.2 ± 1.2	1,159	51	< .001
Ethnicity
Hispanic	2,526	82.5 ± 1.8	533	87.8 ± 1.4	653	88.3 ± 1.1	1,340	33	.0036
Non-Hispanic	12,254	87.9 ± 0.6	3,543	89.3 ± 0.6	3,301	92.3 ± 0.5	5,410	36	< .001
Unknown	6,385	80.8 ± 0.7	3,074	87.9 ± 0.6	3,067	86.3 ± 2.9	244	28	< .001
Immunophenotype
B cell	16,518	85.8 ± 0.5	4,957	89.1 ± 0.4	5,716	92.0 ± 0.5	5,845	44	< .001
T cell	1,825	70.8 ± 1.7	746	80.8 ± 1.7	622	81.5 ± 2.2	457	37	< .001